Kerala Ayurveda Ltd. (KERALAYUR) Share Price Trades Within 2% of 52-Week Low
- August 7, 2026
- Posted by: Lakshit Sharma
- Category: News
Kerala Ayurveda Ltd. Share Price stands at Rs 148.95, with the stock trading within 2% of its 52-week low. The company’s market capitalisation is Rs 203.7 crore.
Kerala Ayurveda Ltd. Share Price was at Rs 148.95 when the Univest screener flagged the stock on 07 August 2026 at 4:26:24 PM IST as trading within 2% of its 52-week low. With a market capitalisation of Rs 203.7 crore, the move places the small-cap Healthcare name in focus for investors tracking one-year low signals, valuation stress and balance-sheet quality.
This is relevant because a stock trading close to its yearly low often draws attention from both market watchers and fundamental investors, but the supplied data only confirms the price event and not a company-specific catalyst. In Kerala Ayurveda Ltd. Share Price terms, the event-level last traded price was Rs 148.95, which matches the reported current price at qualification.
Univest data also shows that Kerala Ayurveda Ltd. Share Price is being watched against a difficult profitability backdrop. The company’s P/E stands at -11.69, P/B at -16.76, ROE at -183.03 and ROCE at -0.45. Those figures matter because they help explain why the stock can remain under pressure even as investors monitor whether valuation and sector positioning begin to stabilise.
Kerala Ayurveda Ltd. Share Price Today: Within 2% of 52-Week Low
| Metric | Value |
|---|---|
| LTP at 2% Qualification | Rs 148.95 |
| Market Capitalisation | Rs 203.7 crore |
| 52-Week Low Position | Trading within 2% of its 52-week low |
Kerala Ayurveda Ltd. (KERALAYUR) traded at Rs 148.95. Reported volume was 18,097.
Kerala Ayurveda Ltd. Share Price Today is Rs 148.95, and the Univest screener identifies the stock as trading within 2% of its 52-week low. That specific setup does not confirm a breach of the one-year bottom, but it does indicate that the stock is trading very close to an important long-term reference zone that many market participants track closely.
In practical terms, when Kerala Ayurveda Ltd. Share Price stays near a 52-week low, investors usually start paying closer attention to whether the market is pricing in weak earnings quality, balance-sheet stress, industry underperformance or a wider de-rating in smaller companies. Here, the supplied data confirms the proximity event and shows the company’s market capitalisation at Rs 203.7 crore, keeping it in the smaller end of the listed Pharmaceuticals & Drugs universe.
The event-qualified last traded price is Rs 148.95, which is also the current price in the supplied dataset. Because the verified data does not provide the exact 52-week low reference price, the relevant factual conclusion is that Kerala Ayurveda Ltd. Share Price remains within striking distance of that one-year low level rather than making any stronger claim. For stock-specific news searches, this makes Kerala Ayurveda Ltd. Share Price News notable because low-zone trading often triggers fresh comparison with sector multiples, profitability trends and peer positioning. That broader context matters more here than short-term interpretation alone, which is why the next step is to examine the company’s fundamentals.
Kerala Ayurveda Ltd. (KERALAYUR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 203.7 crore |
| P/E Ratio | -11.69x |
| P/B Ratio | -16.76x |
| ROE | -183.03% |
| ROCE | -0.45% |
| EPS | Rs -12.74 |
| Book Value Per Share | Rs -9.31 |
| Dividend Yield | 0% |
Kerala Ayurveda Ltd. was valued at a P/E ratio of -11.69x, a P/B ratio of -16.76x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -183.03% and ROCE of -0.45%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs -12.74, book value per share of Rs -9.31, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | -11.69x |
| Benchmark Median P/E | 18.77x |
| Benchmark Average P/E | 62.32x |
| Benchmark P/E Range | 0x to 3,493.04x |
| Company P/B Ratio | -16.76x |
| Benchmark Median P/B | 1.86x |
| Company ROE | -183.03% |
| Benchmark Median ROE | 10.59% |
| Company ROCE | -0.45% |
| Benchmark Median ROCE | 12.98% |
| Company Market Capitalisation | Rs 203.7 crore |
| Benchmark Median Market Cap | Rs 144.13 crore |
Kerala Ayurveda Ltd. (KERALAYUR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kerala Ayurveda Ltd. (KERALAYUR) has a P/E ratio of -11.69x, which is below the benchmark median of 18.77x, a difference of -162.28%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kerala Ayurveda Ltd. (KERALAYUR) has a ROE of -183.03%, which is below the benchmark median of 10.59%, a difference of -1,828.33%. Kerala Ayurveda Ltd. (KERALAYUR) has a ROCE of -0.45%, which is below the benchmark median of 12.98%, a difference of -103.47%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Accretion Pharmaceuticals Ltd. | ACCPL-ST | 199.92 | 20.68 | 3.83 | 27.18 | 12.62 |
| Coral Laboratories Ltd. | CORALAB | 199.35 | 12.17 | 0.95 | 10.74 | 13.35 |
| Gennex Laboratories Ltd. | GENNE | 216.22 | 10.46 | 0.99 | 10.71 | 13.24 |
| Accretion Nutraveda Ltd. | ANL | 219.73 | 43.35 | 6.19 | 106.65 | 21.4 |
| BIO MEDICA LABORATORIES L | BMLL-SM | 188.69 | 16.17 | 10.41 | 13.67 | 10.17 |
Kerala Ayurveda Ltd. (KERALAYUR) has a P/E ratio of -11.69x compared with the displayed peer median of 16.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -183.03% compares with a peer median of 13.67% across the companies shown in the table. ROCE stood at -0.45% versus the displayed peer median of 13.24%, providing a capital-efficiency comparison. Kerala Ayurveda Ltd. (KERALAYUR) has a market capitalisation of Rs 203.7 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Kerala Ayurveda Ltd.
- Kerala Ayurveda Ltd. Share Price is at Rs 148.95 and is trading within 2% of its 52-week low, a setup that naturally attracts market attention.
- The company’s market capitalisation is Rs 203.7 crore, placing it in the smaller-cap segment of the Healthcare space.
- Fundamental metrics are weak, with P/E at -11.69, P/B at -16.76, ROE at -183.03, ROCE at -0.45 and EPS at -12.74.
- Book value per share is -9.31 and dividend yield is 0, limiting balance-sheet and payout support in the current snapshot.
- Industry benchmarks across 136 companies show the company trailing median profitability and valuation norms on a like-for-like Pharmaceuticals & Drugs basis.
- Peer data from similarly sized listed companies shows Kerala Ayurveda Ltd. lagging comparable firms on P/E, P/B, ROE and ROCE.
About Kerala Ayurveda Ltd.
Kerala Ayurveda Ltd. is classified in the Healthcare sector and operates within the Pharmaceuticals & Drugs industry in the supplied Univest dataset. That positioning means Kerala Ayurveda Ltd. Share Price is best analysed alongside other listed pharmaceutical and healthcare businesses rather than against unrelated sectors.
From a market-structure perspective, the company is part of a broad same-industry comparison universe of 136 companies and a wider Healthcare sector base of 197 companies. Its market capitalisation of Rs 203.7 crore places it around the smaller end of the listed spectrum, though still above the industry median market value of Rs 144.13 crore. Because the verified dataset for this article is focused mainly on market, valuation and benchmark fields, the most reliable company context comes from its sector and industry classification. On Univest, investors tracking Kerala Ayurveda Ltd. Share Price can therefore evaluate it through the lens of Pharmaceuticals & Drugs valuation multiples, return ratios, peer positioning and 52-week trading levels.
Track Kerala Ayurveda Ltd. Share Price on Univest
Use Kerala Ayurveda Ltd. (KERALAYUR) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors using Univest can track Kerala Ayurveda Ltd. Share Price with live market context, including current price movement, 52-week levels, valuation ratios, sector comparisons and peer positioning. For a stock trading near its one-year low, that broader view is often more useful than looking at the price in isolation.
Univest also helps users follow Kerala Ayurveda Ltd. Share Price Today alongside metrics such as market capitalisation, P/E, P/B, ROE, ROCE, EPS, book value and dividend yield where available. Because Kerala Ayurveda Ltd. Share Price is currently close to its yearly low, tracking how these metrics compare with industry medians and listed peers can help investors monitor the stock more systematically.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Kerala Ayurveda Ltd. Share Price today?
Ans. Kerala Ayurveda Ltd. Share Price was Rs 148.95 at the event time flagged by Univest on 07 August 2026 at 4:26:24 PM IST. The same dataset also shows the company’s market capitalisation at Rs 203.7 crore.
Why is Kerala Ayurveda Ltd. Share Price in focus today?
Ans. Kerala Ayurveda Ltd. Share Price is in focus because the stock is trading within 2% of its 52-week low, according to the Univest screener. Such proximity to a one-year low typically draws added attention to valuation and profitability metrics.
What does the current market capitalisation indicate for Kerala Ayurveda Ltd.?
Ans. Kerala Ayurveda Ltd. has a market capitalisation of Rs 203.7 crore. Within the same-industry benchmark of 136 companies, that is above the median of Rs 144.13 crore but below the average of Rs 502.66 crore.
Is Kerala Ayurveda Ltd. profitable based on the supplied data?
Ans. The supplied data points to weak profitability. Kerala Ayurveda Ltd. reports a P/E of -11.69, EPS of -12.74, ROE of -183.03 and ROCE of -0.45, indicating losses and negative return ratios in the current snapshot.
What does Kerala Ayurveda Ltd.’s book value and P/B ratio show?
Ans. Kerala Ayurveda Ltd. shows a book value per share of -9.31 and a P/B ratio of -16.76. Those figures suggest negative accounting net worth, which is materially different from the industry median P/B of 1.86.
Does Kerala Ayurveda Ltd. offer any dividend yield right now?
Ans. The supplied dataset shows Kerala Ayurveda Ltd. with a dividend yield of 0. That means there is no current historical yield support in this snapshot while the stock is trading close to its 52-week low.
How does Kerala Ayurveda Ltd. compare with its industry on valuation?
Ans. Kerala Ayurveda Ltd. has a P/E of -11.69 versus the same-industry median of 18.77 and average of 62.32. Its P/B is -16.76, compared with the industry median of 1.86 and average of 2.63.
How does Kerala Ayurveda Ltd. compare with the supplied peers?
Ans. Kerala Ayurveda Ltd. has a market capitalisation of Rs 203.7 crore, similar to several supplied peers, but its P/E, P/B, ROE and ROCE are weaker than peers such as Coral Laboratories, Gennex Laboratories and Accretion Pharmaceuticals.